25,453 recruiting studies available now
This phase II trial tests whether low-dose aspirin can affect markers of inflammation in postpartum (after childbirth) women planning to have a breast biopsy. …
Actual pay is set by the research site.
The purpose of this innovative adaptive phase II trial design is to determine the optimal combination of hyperbaric oxygen treatment parameters that is most li…
Actual pay is set by the research site.
This study measures participant satisfaction and upper extremity function in outpatients with chronic stroke when exposed to the IVS3 device. Investigators hyp…
Actual pay is set by the research site.
CSP #2036 is a pragmatic, randomized, intent-to-treat, two-arm, parallel, multicenter CSP trial. Blinding of clinical staff and participants will not be possib…
Actual pay is set by the research site.
The purpose of this study is to determine if a regular meditation and breath work practice started before surgery and continued through post-surgical recovery …
Actual pay is set by the research site.
This study will validate the diagnostic accuracy of a cutaneous hydration sensor. This sensor will also be evaluated for its feasibility as a point-of-care dev…
Actual pay is set by the research site.
This is a non-interventional, observational, global, multicenter, study describing participant characteristics, clinical outcomes, and event rates in participa…
Actual pay is set by the research site.
In this study the investigators will quantitate hepatic mitochondrial fluxes in T2D patients with NAFL and NASH before and after 16-weeks treatment with the in…
Actual pay is set by the research site.
This is a pilot study to (1) evaluate the effect of Ketorolac on inflammatory response and its impact on stent related symptoms in patients undergoing stent pl…
Actual pay is set by the research site.
This is a multicenter, randomized, double-blind, placebo-controlled Phase 3 maintenance study to evaluate the efficacy and safety of duvakitug in participants …
Actual pay is set by the research site.
This is a phase 1/2 clinical study to evaluate the safety, preliminary efficacy, immunogenicity, and pharmacokinetic (PK) characteristics of SKG0106 in subject…
Actual pay is set by the research site.
This randomized phase II trial will characterize the efficacy, adverse event (AE) profile, and safety of two regimens of 5-FU given as 2L+ treatment to patient…
Actual pay is set by the research site.